BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 28038711)

  • 41. Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.
    Naito T; Umemura S; Nakamura H; Zenke Y; Udagawa H; Kirita K; Matsumoto S; Yoh K; Niho S; Motoi N; Aokage K; Tsuboi M; Ishii G; Goto K
    Thorac Cancer; 2019 May; 10(5):1285-1288. PubMed ID: 30972962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
    Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
    Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [SMARCA4-deficient thoracic tumors: A new entity].
    Decroix E; Leroy K; Wislez M; Fournel L; Alifano M; Damotte D; Mansuet-Lupo A
    Bull Cancer; 2020 Jan; 107(1):41-47. PubMed ID: 31916995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]   [Full Text] [Related]  

  • 45. SWI/SNF Alterations in Squamous Bladder Cancers.
    Achenbach F; Rose M; Ortiz-Brüchle N; Seillier L; Knüchel R; Weyerer V; Hartmann A; Morsch R; Maurer A; Ecke TH; Garczyk S; Gaisa NT
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33227989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
    Zhou P; Fu Y; Tang Y; Jiang L; Wang W
    PeerJ; 2024; 12():e16923. PubMed ID: 38374950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
    Huang SC; Ng KF; Chang IY; Chang CJ; Chao YC; Chang SC; Chen MC; Yeh TS; Chen TC
    PLoS One; 2021; 16(1):e0245356. PubMed ID: 33481850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution.
    Sun S; Li Q; Zhang Z; Xiong S; Zhang Y; Liu Q; Li Z; Yang F; Zhang S
    Environ Health Prev Med; 2022; 27():3. PubMed ID: 35289322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
    Chatzopoulos K; Boland JM
    Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SMARCA4: Current status and future perspectives in non-small-cell lung cancer.
    Tian Y; Xu L; Li X; Li H; Zhao M
    Cancer Lett; 2023 Feb; 554():216022. PubMed ID: 36450331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]   [Full Text] [Related]  

  • 53. SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study.
    Chen IY; Ettel MG; Bell PD; Huber AR; Findeis-Hosey JJ; Wang W; Hezel AF; Dunne RF; Drage MG; Agostini-Vulaj D
    Hum Pathol; 2024 Feb; 144():40-45. PubMed ID: 38307342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
    Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
    J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]   [Full Text] [Related]  

  • 57. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
    Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
    Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.
    Köbel M; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Stewart CJR; Lee CH
    Am J Surg Pathol; 2018 Jan; 42(1):76-83. PubMed ID: 28863077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.